109 related articles for article (PubMed ID: 37642183)
1. Intercellular Interactions Mediated by HGF And TGF-Β Promote the 3D Spherical and Xenograft Growth of Liver Cancer Cells.
Peng Z; Lv X; Zhang P; Chen Q; Zhang H; Chen J; Ma X; Ouyang B; Hao M; Tong H; Guo D; Luo Y; Huang S
Curr Protein Pept Sci; 2024; 25(1):71-82. PubMed ID: 37642183
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.
Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
Mol Cancer Res; 2008 Oct; 6(10):1521-33. PubMed ID: 18922968
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of transforming growth factor-β signaling potentiates tumor cell invasion into collagen matrix induced by fibroblast-derived hepatocyte growth factor.
Oyanagi J; Kojima N; Sato H; Higashi S; Kikuchi K; Sakai K; Matsumoto K; Miyazaki K
Exp Cell Res; 2014 Aug; 326(2):267-79. PubMed ID: 24780821
[TBL] [Abstract][Full Text] [Related]
4. Extracellular signal-regulated kinase and Akt activation play a critical role in the process of hepatocyte growth factor-induced epithelial-mesenchymal transition.
Tanahashi T; Osada S; Yamada A; Kato J; Yawata K; Mori R; Imai H; Sasaki Y; Saito S; Tanaka Y; Nonaka K; Yoshida K
Int J Oncol; 2013 Feb; 42(2):556-64. PubMed ID: 23229794
[TBL] [Abstract][Full Text] [Related]
5. Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma.
Papa E; Weller M; Weiss T; Ventura E; Burghardt I; Szabó E
Cell Death Dis; 2017 Dec; 8(12):3210. PubMed ID: 29238047
[TBL] [Abstract][Full Text] [Related]
6. Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-beta1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor.
Horowitz JC; Lee DY; Waghray M; Keshamouni VG; Thomas PE; Zhang H; Cui Z; Thannickal VJ
J Biol Chem; 2004 Jan; 279(2):1359-67. PubMed ID: 14576166
[TBL] [Abstract][Full Text] [Related]
7. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.
Nakamura T; Matsumoto K; Kiritoshi A; Tano Y; Nakamura T
Cancer Res; 1997 Aug; 57(15):3305-13. PubMed ID: 9242465
[TBL] [Abstract][Full Text] [Related]
8. Neotuberostemonine and tuberostemonine ameliorate pulmonary fibrosis through suppressing TGF-β and SDF-1 secreted by macrophages and fibroblasts via the PI3K-dependent AKT and ERK pathways.
Fu S; Song X; Hu Y; Zhu Q; Lv X; Tang X; Zhang M
Chin J Nat Med; 2023 Jul; 21(7):527-539. PubMed ID: 37517820
[TBL] [Abstract][Full Text] [Related]
9. Transient tumor-fibroblast interactions increase tumor cell malignancy by a TGF-Beta mediated mechanism in a mouse xenograft model of breast cancer.
Stuelten CH; Busch JI; Tang B; Flanders KC; Oshima A; Sutton E; Karpova TS; Roberts AB; Wakefield LM; Niederhuber JE
PLoS One; 2010 Mar; 5(3):e9832. PubMed ID: 20352126
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor attenuates transforming growth factor-β-angiotensin II crosstalk through inhibition of the PTEN/Akt pathway.
Iekushi K; Taniyama Y; Kusunoki H; Azuma J; Sanada F; Okayama K; Koibuchi N; Iwabayashi M; Rakugi H; Morishita R
Hypertension; 2011 Aug; 58(2):190-6. PubMed ID: 21670418
[TBL] [Abstract][Full Text] [Related]
11. Blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathways by statins reduces the expression of bFGF, HGF, and TGF-β as angiogenic factors in mouse osteosarcoma.
Tsubaki M; Yamazoe Y; Yanae M; Satou T; Itoh T; Kaneko J; Kidera Y; Moriyama K; Nishida S
Cytokine; 2011 Apr; 54(1):100-7. PubMed ID: 21292498
[TBL] [Abstract][Full Text] [Related]
12. Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line.
Hasina R; Matsumoto K; Matsumoto-Taniura N; Kato I; Sakuda M; Nakamura T
Br J Cancer; 1999 Aug; 80(11):1708-17. PubMed ID: 10468286
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cells.
Inoue T; Chung YS; Yashiro M; Nishimura S; Hasuma T; Otani S; Sowa M
Jpn J Cancer Res; 1997 Feb; 88(2):152-9. PubMed ID: 9119743
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met.
Mueller KL; Madden JM; Zoratti GL; Kuperwasser C; List K; Boerner JL
Breast Cancer Res; 2012 Jul; 14(4):R104. PubMed ID: 22788954
[TBL] [Abstract][Full Text] [Related]
15. Enhanced hepatocyte growth factor signaling by type II transforming growth factor-beta receptor knockout fibroblasts promotes mammary tumorigenesis.
Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
Cancer Res; 2007 May; 67(10):4869-77. PubMed ID: 17495323
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor counteracts transforming growth factor-beta1, through attenuation of connective tissue growth factor induction, and prevents renal fibrogenesis in 5/6 nephrectomized mice.
Inoue T; Okada H; Kobayashi T; Watanabe Y; Kanno Y; Kopp JB; Nishida T; Takigawa M; Ueno M; Nakamura T; Suzuki H
FASEB J; 2003 Feb; 17(2):268-70. PubMed ID: 12475893
[TBL] [Abstract][Full Text] [Related]
17. Norcantharidin combined with EGFR-TKIs overcomes HGF-induced resistance to EGFR-TKIs in EGFR mutant lung cancer cells via inhibition of Met/PI3k/Akt pathway.
Wu H; Fan F; Liu Z; Shen C; Wang A; Lu Y
Cancer Chemother Pharmacol; 2015 Aug; 76(2):307-15. PubMed ID: 26063323
[TBL] [Abstract][Full Text] [Related]
18. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
[TBL] [Abstract][Full Text] [Related]
19. Cancer Associated Fibroblast-Derived Hepatocyte Growth Factor Inhibits the Paclitaxel-Induced Apoptosis of Lung Cancer A549 Cells by Up-Regulating the PI3K/Akt and GRP78 Signaling on a Microfluidic Platform.
Ying L; Zhu Z; Xu Z; He T; Li E; Guo Z; Liu F; Jiang C; Wang Q
PLoS One; 2015; 10(6):e0129593. PubMed ID: 26115510
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor suppresses transforming growth factor-beta-1 and type III collagen in human primary renal fibroblasts.
Mou S; Wang Q; Shi B; Gu L; Ni Z
Kaohsiung J Med Sci; 2009 Nov; 25(11):577-87. PubMed ID: 19858036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
